Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Cedars-Sinai Outpatient Cancer Center8700 Beverly Blvd. |
Principal Investigator: |
Charles Forsher, MD |
|---|---|
Contact: |
Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute Phone: (310) 423-7585 Alt Phone: (800) 2-CANCER Fax: (310) 652-8759 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cedars-Sinai Outpatient Cancer Center Website: |
http://apps.csmc.edu/SearchClinicalTrials/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.